Luis Rios

Luis Rios, PhD is the Founder and CEO of Fission Pharma, a start-up focused on revolutionizing the treatment of inflammatory diseases. With a background in chemical and systems biology, Luis serves as a Longevity Biotech Fellow at Longevity Biotech Fellowship, Director of Drug Discovery at ImmuneAGE Pharma, Consultant at Longitude Capital, and Scientific Advisor at Healthspan Capital. Previously, Luis was a Senior Scientific Partner at Vine Ventures, a Co-Founder at Avia Pervia, and a Doctoral Student at Stanford University. Luis also holds a Bachelor of Arts in Molecular and Cell Biology from the University of California, Berkeley.